Evidence map›Paper›PMID 33599112›Full record

ArticleStem cells translational medicine2021

Ex vivo conditioning of peripheral blood mononuclear cells of diabetic patients promotes vasculogenic wound healing.

Rica Tanaka, Rie Ito-Hirano, Satoshi Fujimura, Kayo Arita, Hiroko Hagiwara, Tomoya Mita, Masayoshi Itoh, Hideya Kawaji, Takasuke Ogawa, Hirotaka Watada and 3 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Article
  3. Diabetes, Protein Misfolding, and Heat Stress: Molecular Insights and Translational Perspectives.TH open : companion journal to thrombosis and haemostasis · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Endothelial progenitor cells in pregnancy-related diseases.Clinical science (London, England : 1979) · 2023
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Rica TanakaDivision of Regenerative Therapy, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID 0000-0002-6370-0915
Rie Ito-HiranoDivision of Regenerative Therapy, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Satoshi FujimuraDivision of Regenerative Therapy, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kayo AritaDivision of Regenerative Therapy, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hiroko HagiwaraDepartment of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Tomoya MitaDepartment of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Masayoshi ItohRIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Japan.
Hideya KawajiRIKEN Preventive Medicine and Diagnosis Innovation Program, Wako, Japan.
Takasuke OgawaDepartment of Dermatology, Juntendo University School of Medicine, Tokyo, Japan.
Hirotaka WatadaDepartment of Metabolism & Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Haruchika MasudaDepartment of Basic Clinical Science, Division of Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan.
Takayuki AsaharaDepartment of Basic Clinical Science, Division of Regenerative Medicine, Tokai University School of Medicine, Isehara, Japan.
Hiroshi MizunoDepartment of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Juntendo University · JPTokai University · JPRIKEN · JPTokyo Metropolitan Institute of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quality and quantity of endothelial progenitor cells (EPCs) are impaired in patients with diabetes mellitus patients, leading to reduced tissue repair during autologous EPC therapy. This study aimed to address the limitations of the previously described serum-free Quantity and Quality Control Culture System (QQc) using CD34+ cells by investigating the therapeutic potential of a novel mononuclear cell (MNC)-QQ. MNCs were isolated from 50 mL of peripheral blood of patients with diabetes mellitus and healthy volunteers (n = 13 each) and subjected to QQc for 7 days in serum-free expansion media with VEGF, Flt-3 ligand, TPO, IL-6, and SCF. The vascular regeneration capability of MNC-QQ cells pre- or post-QQc was evaluated with an EPC colony-forming assay, FACS, EPC culture, tube formation assay, and quantitative real time PCR. For in vivo assessment, 1 × 10

Indexed as

Diabetes MellitusLeukocytes, MononuclearWound HealingAnimalsCulture Media, Serum-FreeHumansMiceMice, Inbred BALB CMice, NudeNeovascularization, PhysiologicCulture Media, Serum-Freediabetes mellitusmononuclear cell therapyperipheral blood mononuclear cellsquantity and quality control culture techniquevasculogenesiswound healing

Identifiers

PMID33599112
PMCPMC8133343
OpenAlexW3133065072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.